%0 Journal Article
%T Clinical value of an adenosine triphosphate-based chemotherapy response assay in resectable stage III colorectal cancer
%A Chan Dong Kim
%A Jae Hwang Kim
%A Sang Hoon Jung
%A So Hyun Kim
%J Archive of "Annals of Surgical Treatment and Research".
%D 2019
%R 10.4174/astr.2019.97.2.93
%X ATP-based chemotherapy response assay (ATP-CRA) is a well-documented and validated technology that can individualize chemotherapy. This study was undertaken to assess the usefulness of ATP-CRA in advanced colorectal cancer (CRC) patients receiving adjuvant chemotherapy
%K Adenosine triphosphate
%K Antitumor drug screening assays
%K Colorectal neoplasms
%K FOLFOX regimen
%K adjuvant chemotherapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669130/